CoChat

Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA.

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

A transferrin receptor-targeted antibody transport vehicle improved brain distribution and reduced ARIA-like lesions in mice.

Overview

Integrity signals

Registry

Crossref · 10.1126/science.ads3204

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 77 references

Research works printed but not linked: 2

  1. T. Bussiere J. Abettan J. Sebalusky S. Hamann A. Silva Amaral D. Walsh D. Bradley E. Plowey “Modeling mechanisms of amyloid-related imaging abnormalities (aria) in transgenic mice treated with anti-aβ immunotherapy and imaged with MRI.” abstract #425 oral presentation at AD/PD 5-9 March 2024 Lisbon Portugal [Preprint] (2024); https://cslide.ctimeetingtech.com/adpd24/attendee/confcal/show/session/14#presentation-abstract-42585247580.
  2. V. O. Torres M. E. Pizzo D. Chan J. C. Dugas D. Huynh D. Joy E. K. Liang L. Sarrafha I. Becerra R. Chau K. S. Chew J. Chow T. K. Earr N. Khoury K. J. Lechtenberg A. W. Leung H. N. Nguyen E. S. Ojo E. Roche H. Solanoy M. Tong R. K. Tong K. Henne J. W. Lewcock R. J. Watts M. E. Calvert R. G. Thorne Y. J. Y. Zuchero Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development but maintained across adult aging. BioRxiv 10.1101/2024.11.12.623253 [Preprint] (2024); https://doi.org/10.1101/2024.11.12.623253.10.1101/2024.11.12.623253 · DOI

Cited by

See all 63

Metadata

Authors
Pizzo, M. E., Plowey, E. D., Khoury, N., Kwan, W., Abettan, J., DeVos, S. L., Discenza, C. B., Earr, T., Joy, D., Lye-Barthel, M., Roche, E., Chan, D., Dugas, J. C., Gadkar, K., Hamann, S., Meisner, R., Sebalusky, J., Silva Amaral, A. C., Becerra, I., Chau, R., Chow, J., Clemens, A. J., Dennis, M. S., Duque, J., Fusaro, L., Getz, J. A., Kariolis, M. S., Kim, D. J., Lechtenberg, K. J., Leung, A. W.-S., Moshkforoush, A., Nguyen, H. N., Ojo, E. S., Thomsen, E. R., Torres, V. O., Sanchez, P. E., Shan, L., Silverman, A. P., Sweeney, Z. K., Solanoy, H., Tong, R., Calvert, M. E., Watts, R. J., Thorne, R. G., Weinreb, P. H., Walsh, D. M., Lewcock, J. W., Bussiere, T., & Zuchero, Y. J. Y.
Affiliations
  • Denali Therapeutics (United States) (US)
  • Biogen (United States) (US)
  • Biogen, Cambridge, MA, USA.
  • Denali Therapeutics, Inc., South San Francisco, CA, USA.
  • University of Minnesota (US)
Corresponding author
Zuchero, Y. Joy Yu
Venue
Science
Published
2025-08-07
Volume
389
Issue
6760
Pages
eads3204-eads3204
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W4413045841
Cited by
63
References
73
Citations by year
2026: 49 · 2025: 14
FWCI
40.15
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
amyloid-related imaging abnormalities, anti-amyloid therapy, transferrin receptor, amyloid-beta immunotherapy, brain drug delivery, blood-brain barrier, Alzheimer's disease, vascular inflammation, amyloid plaques, antibody biodistribution
MeSH terms
Alzheimer Disease, Animals, Antibodies, Monoclonal, Blood-Brain Barrier, Brain, Humans, Immunoglobulin Fc Fragments, Magnetic Resonance Imaging, Mutation, Receptors, Transferrin, Tissue Distribution, Amyloid beta-Peptides, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA. https://app.cochat.ai/papers/10.1126/science.ads3204
The paper
Pizzo, M. E., Plowey, E. D., Khoury, N., Kwan, W., Abettan, J., DeVos, S. L., Discenza, C. B., Earr, T., Joy, D., Lye-Barthel, M., Roche, E., Chan, D., Dugas, J. C., Gadkar, K., Hamann, S., Meisner, R., Sebalusky, J., Silva Amaral, A. C., Becerra, I., . . . Zuchero, Y. J. Y. (2025). Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA. Science. https://doi.org/10.1126/science.ads3204

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.